Home » Topics » BioWorld Science

BioWorld Science
RSS

Generic aciclovir approved by FDA

June 9, 1997

DepoTech reacquires certain marketing rights to DepoCyt

June 9, 1997

Multinational trial assesses efficacy and safety of tolterodine for incontinence

June 9, 1997

DHEA enters phase II/III trials

June 9, 1997

Aciclovir demonstrates antiasthmatic activity in animal model

June 9, 1997

Salix Holdings: Q1 1997 highlights

June 9, 1997

Fujisawa: FY 1997 highlights

June 9, 1997

Nycomed: Q1 1997 highlights

June 9, 1997

New pharmacological data reported for Novo Nordisk/Lilly muscarinic agent

June 9, 1997

Nymox Pharmaceuticals outlines R&D pipeline

June 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...